$ZNTL 3 SEC Filings

Filed On	Filing
27 May 2026	Form 3: Campbell Shannon, Director No securities owned
08 Jan 2026	Form 3: Walters Group, 10% owner and 2 others Holds 7,050,000 shares of Common Stock
22 Sep 2025	Form 3: Bucher James B, Chief Legal Officer No securities owned
13 Nov 2024	Form 3: Bruns Ingmar, Chief Medical Officer No securities owned
13 Nov 2024	Form 3: Eastland Julia Marie, Director No securities owned
13 Nov 2024	Form 3: Myers Scott Dunseth, Director No securities owned
29 May 2024	Form 3: Walker Luke Nathaniel, Director No securities owned
11 Apr 2024	Form 3: Vultaggio Vincent, Principal Accounting Officer Holds 35,458 shares of Common Stock
03 Jan 2024	Form 3: Lackner Mark, Chief Scientific Officer Holds 16,313 shares of Common Stock
10 May 2023	Form 3: Hausman Diana, Director No securities owned
13 Feb 2023	Form 3: Roth Iris, Chief Operating Officer No securities owned
03 Oct 2022	Form 3: Brownstein Carrie, Chief Medical Officer No securities owned
12 Sep 2022	Form 3: Skvarka Jan, Director No securities owned
01 Aug 2022	Form 3: Paul Andrea, General Counsel No securities owned
03 Jun 2022	Form 3: Matrix Capital Management Company, Lp, 10% owner and 1 other Holds 9,199,973 shares of Common Stock, par value $0.001 per share
10 Feb 2021	Form 3: Kariuki Enoch, Director No securities owned
01 Sep 2020	Form 3: Pinto Alexis, Chief Legal Officer No securities owned
01 Jul 2020	Form 3: Blackwell Kimberly, Director No securities owned
03 Apr 2020	Form 3: Voliotis Dimitris, SVP, Clinical Development
03 Apr 2020	Form 3: Recurium Equity, Llc, 10% owner Holds 4,162,930 shares of Common Stock

Comments